{"id":69267,"date":"2020-09-15T01:00:00","date_gmt":"2020-09-15T01:00:00","guid":{"rendered":"https:\/\/icrowdnewswire.com\/?p=2727418"},"modified":"2020-09-15T01:00:00","modified_gmt":"2020-09-15T01:00:00","slug":"cell-therapy-instruments-market-what-is-the-estimated-market-size-in-the-upcoming-years-key-players-cytiva-merck-kgaa-terumo","status":"publish","type":"post","link":"https:\/\/ipsnews.net\/business\/2020\/09\/15\/cell-therapy-instruments-market-what-is-the-estimated-market-size-in-the-upcoming-years-key-players-cytiva-merck-kgaa-terumo\/","title":{"rendered":"Cell Therapy Instruments Market What Is The Estimated Market Size In The Upcoming Years? | key players- Cytiva, MERCK KGaA, Terumo"},"content":{"rendered":"

The cell therapy instruments market<\/a> was valued at US$ 12,340.03 million in 2019 and is projected to reach US$ 32,477.15 million by 2027; it is expected to grow at a CAGR of 13.2% from 2020 to 2027.<\/p>\n

Cell therapy is a procedure where living and intact cells are injected, implanted, or grafted into the patient’s body. For instance, a person who has cancer is injected with T cells during his\/her course of immunotherapy. The cell therapy instruments ranges from injections to surgical implantation using special devices. Cell therapy has applications in a large number of diseases such as nervous system disorders, cancer, cardiac conditions (myocardial infarction and heart failure), diabetes mellitus, bones and joints, genetic disorders, and wounds of the skin and soft tissues.<\/p>\n

Get sample PDF copy at:https:\/\/www.theinsightpartners.com\/sample\/TIPRE00003481\/<\/a><\/strong><\/p>\n

Thermo Fisher Scientific Inc.; MERCK KGaA; Lonza; Cytiva (GE Healthcare Life Sciences); Terumo Corporation; BD; Miltenyi Biotec; STEMCELL Technologies Inc.; Sartorius AG; and Danaher Corporation (Beckman Coulter Inc.) are among the leading companies operating in the cell therapy instruments market.<\/p>\n

Based on product, the cell therapy instruments market is segmented into consumables, equipment, and systems and software. The consumables segment held the largest share of the market in 2019, and is anticipated to register the highest CAGR in the market during the forecast period. Further, the equipment segment is sub-segmented into single-use equipment, cell–processing equipment, and other equipment. The cell processing equipment segment held the largest market share in 2019; whereas, the single-use equipment segment is expected to grow at the fastest CAGR during the forecast period.<\/p>\n

The scope of thecell therapy instruments marketincludes product, cell type, process, end user, and region. The market for cell therapy instruments is analyzed based on regions such as North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the cell therapy instruments market emphasizing on various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the world.<\/p>\n

The use of equipment is important for the production of cell therapies such as T cells, HSC, NSC, PSC, and MSC. These cell therapy products are derived from human or animals cells and thus require safe conditions from contamination. Thus, the instruments used for cell therapies help preventing contamination and allows scaling up the production. For instance, companies such as Corning Incorporated; Thermo Fisher Scientific Inc.; Hitachi Chemical Advanced Therapeutics Solutions, LLC; Invetech; Miltenyi Biotec; and Cytiva (General Electric Company) have introduced various equipment and consumables for the cell therapy.<\/p>\n

Similarly, in May 2019, Cytiva (General Electric Company) commercially introduced a chronicle automation software for cell therapy. The chronicle-automated software comprises a unified digital space that monitors all manufacturing operations and supply chain logistics with real-time data acquisition and notifications. Its electronic batch records trace every manufacturing step with automation and eSOPs designed for specific processes to manage deviations and promote adherence to protocol.<\/p>\n

The report segments global cell therapy instruments market as follows:<\/strong><\/p>\n

By Product<\/p>\n